Tóm tắt
Background: Chronic rhinosinusitis (CRS) is one of the most prevalent chronic conditions, leading to significant health and economic burdens. Health-related quality of life can be reflected by Health Utility Index (HUI). Tools such as the EuroQol-5-Dimensions-5-Levels (EQ-5D-5L) and the Visual Analog Scale (VAS) are widely used to assess HUI in CRS patients. This study aimed to determine the overall HUI of Vietnamese patients with CRS and identify factors influencing it.
Materials and Methods: A cross-sectional study was conducted at Hue University of Medicine and Pharmacy Hospital from January 2024 to December 2024. Patients with a diagnosis of primary CRS were recruited. Clinical data and HUI measurements were collected, and regression models were used to predict the HUI of CRS patients.
Results: A total of 51 patients were enrolled. The overall HUI, as assessed by EQ-5D-5L and VAS, was 0.75 ± 0.15 and 0.73 ± 0.14, respectively. No significant difference was found between the two methods in measuring HUI. Multivariable linear regression revealed that each unit increase in the 22-item Sinonasal Outcome Test (SNOT-22) score reduced the HUI by 0.003, while each unit increase in the VAS score for overall symptoms resulted in a 0.02 decrease in the HUI.
Conclusions: The overall HUI for CRS patients ranged between 0.73 and 0.75. Higher SNOT-22 and VAS for overall symptoms scores were associated with lower HUI, highlighting their negative impact on health utility.
| Đã xuất bản | 30-08-2025 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Tập 15 Số 4 (2025) | |
| Phân mục | Nghiên cứu | |
| DOI | 10.34071/jmp.2025.4.5 | |
| Từ khóa | chronic rhinosinusitis, EQ-5D-5L, health utility index, quality of life, SNOT-22 |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2025 Tạp chí Y Dược Huế
Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213-739
Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009;34(5):447-454
Zhou T, Guan H, Wang L, Zhang Y, Rui M, Ma A. Health-Related Quality of Life in Patients With Different
Diseases Measured With the EQ-5D-5L: A Systematic Review. Front Public Health. 2021;9:675523
Wang L, Poder TG. A systematic review of SF-6D health state valuation studies. J Med Econ. 2023;26(1):584-593
Scangas GA, Rathi VK, Metson RB, et al. Defining the Health Utility Value of Medical Management of Chronic Rhinosinusitis: A Prospective Pilot Study. OTO Open. 2022;6(2):2473974X221092381
Lange B, Holst R, Thilsing T, Baelum J, Kjeldsen A. Quality of life and associated factors in persons with chronic rhinosinusitis in the general population: a prospective questionnaire and clinical cross-sectional study. Clin Otolaryngol. 2013;38(6):474-480
Remenschneider AK, Scangas G, Meier JC, et al. EQ- 5D-derived health utility values in patients undergoing surgery for chronic rhinosinusitis. Laryngoscope. 2015;125(5):1056-1061
Erskine SE, Hopkins C, Clark A, et al. Chronic rhinosinusitis and mood disturbance. Rhinology. 2017;55(2):113-119
Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464
Lildholdt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-
blind, placebo-controlled study of budesonide. Clin Otolaryngol Allied Sci. 1995;20(1):26-30
Mai VQ, Sun S, Minh HV, et al. An EQ-5D-5L Value Set for Vietnam. Qual Life Res. 2020;29(7):1923-1933
Kim do H, Han K, Kim SW. Effect of Chronic Rhinosinusitis With or Without Nasal Polyp on Quality of Life in South Korea: 5th Korea National Health and Nutrition Examination Survey Korean. Clin Exp Otorhinolaryngol. 2016;9(2):150-156
Zhang C, Wang H, Zhang Q, et al. Subjective symptoms as predictors for eosinophilic chronic rhinosinusitis with nasal polyps in the Chinese population. Eur Arch Otorhinolaryngol. 2023;280(8):3721-3729
Sangubol M, Snidvongs K, Lawpoolsri S, Mongkolkul K, Kowatanamongkon P, Chitsuthipakorn W. Health Utility
Score in Thai Patients with Chronic Rhinosinusitis: Pre- and Postoperative Analyses. Laryngoscope. 2024;134(5):2070- 2076
Hoehle LP, Phillips KM, Bergmark RW, Caradonna DS, Gray ST, Sedaghat AR. Symptoms of chronic
rhinosinusitis differentially impact general health-related quality of life. Rhinology. 2016;54(4):316-322
Hansen TM, Stavem K, Rand K. Time trade-off with someone to live for: impact of having significant others on time trade-off valuations of hypothetical health states published correction appears in Qual Life Res. 2022 Oct;31(10):3087
Garza AG, Wyrwich KW. Health utility measures and the standard gamble. Acad Emerg Med. 2003;10(4):360-363
Bognanni A, Chu DK, Rank MA, et al. Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta-analysis. J Allergy Clin Immunol. 2022;150(6):1447-1459